Paul Conyngham used AI to design a personalised experimental treatment for his dog, Rosie. Read more at straitstimes.com. Read more at straitstimes.com.
Ribonucleic acids (RNAs) serve as messengers between DNA and protein production, and perform a wide variety of regulatory functions across different cellular processes. This makes them an interesting ...
Morning Overview on MSN
Researchers identify LENG8 as a key gatekeeper for RNA quality control
A protein called LENG8 traps defective RNA molecules inside the cell nucleus before they can reach the cytoplasm and disrupt normal cellular function, according to a study published in Molecular Cell ...
Once considered cellular junk, non-coding RNAs are emerging as key players in everything from brain development to cancer — ...
3d
CD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid Therapeutics
CD Bioparticles announces the launch of comprehensive Extrahepatic RNA Delivery services. NEW YORK, NY, UNITED STATES, ...
CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to ...
A newly identified cellular system monitors subtle variations in genetic coding, hinting at a hidden level of control over ...
Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...
UT Southwestern discovery could lead to a novel approach for treating heart disease and fatty liver disease. Two researchers ...
Preliminary Phase 1 Study Results Show Strong Anti-Tumor Activity and Favorable Safety Profile for First-in-Class Small Molecule MYB mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results